Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 7,882 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Valvular Heart Disease, Pericardial Disease, Cardiomyopathies
Interventions: Photoplethysmography; Diagnostic Test
Lead sponsor: Tulane University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: New Orleans, Louisiana

Conditions: DIEP Flap, Breast Reconstruction, Breast Cancer
Interventions: Use of ORASIS Device; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Durham, North Carolina • Raleigh, North Carolina

Conditions: Kidney Cancer
Interventions: Perifosine; Drug
Lead sponsor: AEterna Zentaris; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 3
States / cities: Louisville, Kentucky • Morristown, New Jersey • Armonk, New York

Conditions: Chronic Pain Due to Cancer, Pain Catastrophizing
Interventions: Empowered Relief Course (Zoom); Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 120 Years
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Tobacco Use Cessation
Interventions: Brief telephone advice plus tailored text messages, Mailed nicotine replacement therapy, Proactive telephone coaching; Behavioral · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Bipolar 1 Disorder, Major Depressive Disorder
Interventions: Abilify MyCite - Digital Medicine System, Aripiprazole or other oral antipsychotics; Combination Product · Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 63 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 5
States / cities: Santa Rosa, California • Decatur, Georgia • Smyrna, Georgia + 2 more

Conditions: Communication
Interventions: PICU Supports, Educational Brochure; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Not listed
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: VitaBlue™, Placebo, Lovaza®; Drug · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: HIV Seronegativity, Linkage
Interventions: T-POWr Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Los Angeles, California • San Diego, California

Conditions: Overweight and Obesity, Depression, Postpartum, Mother (Person)
Interventions: Madres para la Salud; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 177 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Spasticity
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Diabetes
Interventions: UP FOR IT - practice facilitation, UP FOR IT - health information technology; Other
Lead sponsor: Mary Lacy; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Alcohol Use Disorder
Interventions: Contingency management; Behavioral
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Phenylketonurias
Interventions: Skin Tape, Blood Draw; Other · Diagnostic Test
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Lung Cancer, Metastatic Cancer
Interventions: Cryotherapy (PTC), Prednisone; Procedure · Drug
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pain, Hip Fractures
Interventions: Femoral Nerve Block; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 60 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 3
States / cities: New York, New York

Conditions: Diabetic Retinopathy, Retinal Vein Occlusion, Hypertension,Essential, Retinal Vascular Disorder
Interventions: Swept-Source (SS) OCT Angiography, Spectral-Domain (SD) OCT Angiography, Fundus Imaging, Axial Length Measurement Device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,050 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension, Pulmonary
Interventions: Blood Sample; Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 907 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 16
States / cities: Los Angeles, California • Aurora, Colorado • Jacksonville, Florida + 12 more

Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: Cisplatin, Docetaxel, Laboratory Biomarker Analysis, Pharmacological Study, Therapeutic Conventional Surgery, WEE1 Inhibitor AZD1775; Drug · Other · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Fractures, Closed, Pain, Postoperative, Pain Catastrophizing, Pain, Acute, Analgesia, Opioid Use, Acceptance and Commitment Therapy, Orthopedics, Analgesics, Opioid, Text Messaging
Interventions: Acceptance and Commitment Therapy Delivered via an Automated Mobile Messaging Robot; Behavioral
Lead sponsor: Christopher Anthony; Other
Eligibility: 18 Years to 100 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Posttraumatic Stress Disorder, Anxiety Disorder
Interventions: Propranolol, Reactivation, Mifepristone, Intranasal oxytocin; Drug · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Parkinson Disease, Anxiety
Interventions: Focused breathing; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Hematologic Neoplasms
Interventions: Not listed
Lead sponsor: Center for International Blood and Marrow Transplant Research; Network
Eligibility: 18 Years to 60 Years
Enrollment: 21,974 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 28
States / cities: Duarte, California • Oakland, California • Santa Ana, California + 25 more

Conditions: Autism
Interventions: Fat Harvesting and Stem Cell Injection; Procedure
Lead sponsor: Ageless Regenerative Institute; Industry
Eligibility: 3 Years to 12 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Aventura, Florida

Search by objective public record fields.

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

ORASIS in Breast Reconstruction

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Empowered Relief® for Cancer Survivors With Chronic Pain

Engagement With an Adaptive Mobile Health Smoking Cessation Intervention

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Improving Communication in the PICU: The Navigate Study

COGNUTRIN in Breast Cancer Survivors

Linkage of Transgender Individuals to PrEP

Madres Para la Salud (Mothers for Health)

Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity

Using Practice Facilitation and Operationalizing Referral Information Technology to Increase DSMES Utilization

Automated Reinforcement Management System (ARMS)

PKU Skin Stripping

Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis

Improving Pain and Function in Hip Fracture

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)

WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck

Pain and Narcotic Usage After Orthopaedic Surgery

Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders

Self-Managed Intervention for Anxiety in Parkinson's Disease

National Marrow Donor Program Long-Term Donor Follow-Up

Adipose Derived Stem Cell Therapy for Autism